[HTML][HTML] Total neoadjuvant therapy in rectal cancer: the evidence and expectations
L Boublikova, A Novakova, J Simsa… - Critical Reviews in …, 2023 - Elsevier
Current management of locally advanced rectal cancer achieves high cure rates, distant
metastatic spread being the main cause of patients' death. Total neoadjuvant therapy (TNT) …
metastatic spread being the main cause of patients' death. Total neoadjuvant therapy (TNT) …
Pleasurable and problematic receptive anal intercourse and diseases of the colon, rectum and anus
DR Dickstein, CR Edwards, CR Rowan… - Nature Reviews …, 2024 - nature.com
The ability to experience pleasurable sexual activity is important for human health.
Receptive anal intercourse (RAI) is a common, though frequently stigmatized, pleasurable …
Receptive anal intercourse (RAI) is a common, though frequently stigmatized, pleasurable …
Practice patterns for organ preservation in US patients with rectal cancer, 2006-2020
A Loria, MA Tejani, LK Temple, CF Justiniano… - JAMA …, 2024 - jamanetwork.com
Importance In March 2023, the National Comprehensive Cancer Network endorsed watch
and wait for those with complete clinical response to total neoadjuvant therapy. Neoadjuvant …
and wait for those with complete clinical response to total neoadjuvant therapy. Neoadjuvant …
Oncological risks associated with the planned watch-and-wait strategy using total neoadjuvant treatment for rectal cancer: A narrative review
J Socha, R Glynne-Jones, K Bujko - Cancer Treatment Reviews, 2024 - Elsevier
Overall survival benefit of total neoadjuvant treatment (TNT) remains unconfirmed. Thus, in
our opinion, the main rationale for using TNT is a planned watch-and-wait (w&w) strategy to …
our opinion, the main rationale for using TNT is a planned watch-and-wait (w&w) strategy to …
Validated pretreatment prediction models for response to neoadjuvant therapy in patients with rectal cancer: a systematic review and critical appraisal
MD Tanaka, BM Geubels, BA Grotenhuis… - Cancers, 2023 - mdpi.com
Simple Summary Organ preservation strategies can be offered to patients with rectal cancer
that show a strong response to preoperative treatment in order to avoid major surgery …
that show a strong response to preoperative treatment in order to avoid major surgery …
Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy
A Bercz, BK Park, E Pappou, D Nemirovsky, R Sarkar… - Annals of …, 2024 - Elsevier
Background Potential differences in organ preservation between total neoadjuvant therapy
(TNT) regimens integrating long-course chemoradiotherapy (LCCRT) and short-course …
(TNT) regimens integrating long-course chemoradiotherapy (LCCRT) and short-course …
The ultimate local failure rate after the watch-and-wait strategy for rectal cancer: a systematic review of literature and meta-analysis
J Socha, K Bujko - Acta Oncologica, 2023 - Taylor & Francis
Background We hypothesise that a high rate of tumour regrowth after the watch-and-wait
(w&w) strategy may lead, despite salvage surgery, to a significant impairment of ultimate …
(w&w) strategy may lead, despite salvage surgery, to a significant impairment of ultimate …
Local excision after neoadjuvant chemoradiotherapy for mid and low rectal cancer: a multicentric French study from the GRECCAR group
M Calmels, C Labiad, B Lelong, JH Lefevre… - Colorectal …, 2023 - Wiley Online Library
Aim A complete or subcomplete tumour response (CTR) is observed in 10%–25% of
patients with mid/low rectal cancer after neoadjuvant chemoradiotherapy (CRT). The aim of …
patients with mid/low rectal cancer after neoadjuvant chemoradiotherapy (CRT). The aim of …
Patient and multidisciplinary team perspectives on watch and wait in rectal cancer
H Mohan, M Rabie, C Walsh, D Harji… - Colorectal …, 2023 - Wiley Online Library
This article adopts a multidisciplinary approach, including surgery, oncology, radiology and
patient perspectives, to discuss the key points of debate surrounding a watch and wait …
patient perspectives, to discuss the key points of debate surrounding a watch and wait …
Optimisation of Organ Preservation treatment strategies in patients with rectal cancer with a good clinical response after neoadjuvant (chemo) radiotherapy: Additional …
BM Geubels, B van Triest, FP Peters, M Maas… - BMJ open, 2023 - bmjopen.bmj.com
Introduction Standard treatment for patients with intermediate or locally advanced rectal
cancer is (chemo) radiotherapy followed by total mesorectal excision (TME) surgery. In …
cancer is (chemo) radiotherapy followed by total mesorectal excision (TME) surgery. In …